Stockscreener 앱 받기
365.08
8.33%
28.08
Bio-Rad Laboratories, Inc. Class B 주식(BIO.B)의 최신 뉴스
Neogen (NEOG) Q1 Earnings and Revenues Beat Estimates - Zacks Investment Research
Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.
Bio-Rad Reports Second-Quarter 2026 Financial Results - Investing News Network
Europe Point of Care Diagnostics Market Size and Forecast, 20212031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGR - GlobeNewswire Inc.
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.
Magnetic Beads MarketGlobal Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion - GlobeNewswire Inc.
North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion Opportunity - GlobeNewswire Inc.
Bio-Rad Laboratories, Inc. Class A Revenue Breakdown – HAN:BUWA - tradingview.com
Bio-Rad Laboratories Inc Stock Intrinsic Values | HAM:BUWA - gurufocus.com
Bio-Rad Laboratories Inc Stock Baskets - gurufocus.com
Veterinary Diagnostics Market Size to Soar to USD 30.78 Billion by 2035 at a CAGR of 10.1%SNS Insider - GlobeNewswire Inc.
Global Therapeutic Drug Monitoring Consumables Market Forecast, 2026-2032AI-Enabled Automation and Integrated Lab Workflows Drive 8.22% CAGR, Lifting the Market to USD 586.85 Million by 2032 - GlobeNewswire Inc.
Bio-Rad Laboratories, Inc. (BIO-B) Stock Price, News, Quote & History - Yahoo! Finance Canada
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now - Zacks Investment Research
Global Metabolomics Market to Reach US$9.01 Billion by 2035 as Precision Medicine, Biomarker Discovery and Advanced Analytics Unlock New Opportunities - GlobeNewswire Inc.
Magnetic Bead Purification Kits Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook - GlobeNewswire Inc.
Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum - Investing News Network
Bio-Rad (NYSE: BIO) director sees 320 RSUs convert, 116 shares withheld - Stock Titan
Bio-Rad (NYSE: BIO) EVP logs 4,313 RSU grant and 2,179 vested shares - Stock Titan
1,453 stock units vest for Bio-Rad (NYSE: BIO) insider as 551 shares withheld - Stock Titan
Bio-Rad (NYSE: BIO) grants EVP 4,601 RSUs, with shares withheld at $386.11 - Stock Titan
[Form 4] BIO-RAD LABORATORIES, INC. Insider Trading Activity - Stock Titan
Bio-Rad's Timing for Revenue Growth Recovery Remains Uncertain - Morningstar
Bio-Rad Laboratories Inc. Class A (BIO) Key Financial Ratios – Valuation, Profitability & More - Value Research
RSU vesting gives Bio-Rad (NYSE: BIO) exec 425 shares - Stock Titan
Bio-Rad to Participate in Fireside Chat During Wells Fargo's 21st Annual Healthcare Conference - Investing News Network
Starbucks Upgraded, Ralph Lauren Downgraded: Updated Rankings on Top Blue-Chip Stocks - investorplace.com
Bio-Rad Laboratories Inc. Class A (BIO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Bio-Rad Laboratories Inc. Class A (BIO) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Bioventus Inc. Class A (BVS) Peer Comparison – Compare with Others - Value Research
Koninklijke Philips N.V. NY Registry SharesADR Peer Comparison – Compare with Others - Value Research
Bio-Rad Laboratories (NYSE: BIO) exec vests 246 RSUs, withholds shares - Stock Titan
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026? - The Motley Fool
Bio-Rad Reports First-Quarter 2026 Financial Results - Investing News Network
Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026 - BioSpace
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026 - Investing News Network
Bio-Rad Reports Third-Quarter 2025 Financial Results - Investing News Network
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025 - Investing News Network
Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies - Business Wire
Bio-Rad Laboratories: This Undervalued Stock Offers Investors a Rare Combination - Morningstar
Bio-Rad Laboratories, Inc. (BIO.B) Führung & Management Team Analyse - Simply Wall Street
symbol__ Stock Quote Price and Forecast - CNN
symbol__ Stock Quote Price and Forecast - CNN
Bio-Rad Laboratories, Inc. (BIO.B) Company Information - Simply Wall Street
0.48%
3.35%
자본화:
|
볼륨(24시간):